text_1: Risk of cardiovascular events can be cut by a third by using antihypertensive drug therapy among hemodialysis patients.
text_2: In a sensitivity analysis, we found that the hypertensive group had a pooled hazard ratio of 0.49 (95% CI: 0.35 to 0.67), but when normotensives were included in the trial, lesser cardiovascular protection was seen (pooled hazard ratio of 0.86 [95% CI: 0.67 to 1.12]).